Clinical Research Detail Title Of Study Efficacy and Safety of Daclizumab High Yield Process Versus Interferon ß 1a in Patients With Relapsing-Remitting Multiple Sclerosis. Disease Condition Relapsing Remitting Multiple Sclerosis Phase of Trial Phase-3 Discipline Neurology Start date of Trial 9/30/2010 Closing Date of Trial 9/30/2013 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]